AVR
Anteris Technologies Global Corp.
NASDAQ · Healthcare · Medical - Devices · AU
$8.88
+1.83%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 2.2M | 1.9M | 2.7M | 2.7M | 3.2M |
| Cost of Revenue | 1.4M | 2.2M | 1.4M | 1.9M | 2.9M |
| Gross Profit | 829.0K | (317.0K) | 1.3M | 876.8K | 298.4K |
| Operating Expenses | |||||
| R&D Expense | 77.2M | 69.1M | 51.5M | 31.0M | 17.6M |
| SG&A Expense | 24.2M | 24.5M | — | 17.0M | 15.2M |
| General & Admin Expense | 8.4M | — | — | 16.0M | 14.4M |
| Selling & Marketing Expense | — | — | — | 1.1M | 806.3K |
| Other Expenses | 5.8M | — | 28.2M | 949.5K | (1.4M) |
| Total Operating Expenses | 107.1M | 93.6M | 79.6M | 49.0M | 31.4M |
| Cost and Expenses | 108.5M | 95.8M | 81.1M | 50.9M | 34.3M |
| Operating Income (EBIT) | (106.2M) | (93.9M) | (78.4M) | (48.1M) | (31.1M) |
| Non-Operating | |||||
| Interest Income | — | 709.0K | — | 428.1K | 210.4K |
| Interest Expense | 52.0K | 73.0K | 82.0K | 67.1K | 648.7K |
| Net Interest Income | (52.0K) | 636.0K | (82.0K) | 361.0K | (438.3K) |
| Other Non-Op Income/Expense | 3.8M | (331.0K) | 2.4M | 1.4M | 550.5K |
| Non-Operating Income (excl Interest) | (3.9M) | 258.0K | (2.5M) | (1.4M) | (1.2M) |
| EBT (Pre-Tax Income) | (102.4M) | (94.2M) | (76.0M) | (46.8M) | (30.6M) |
| Income Tax Expense | 809.0K | — | — | — | — |
| Bottom Line | |||||
| Net Income | (103.6M) | (94.1M) | (76.3M) | (46.0M) | (30.6M) |
| Earnings from Cont. Ops | (103.2M) | (94.2M) | (76.0M) | (46.8M) | (30.6M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (103.6M) | (94.1M) | (76.3M) | (46.0M) | (30.6M) |
| Per Share | |||||
| Basic EPS | ($2.76) | ($2.55) | ($3.77) | ($1.28) | ($0.85) |
| Diluted EPS | ($2.76) | ($2.55) | ($3.77) | ($1.28) | ($0.85) |
| Revenue Per Share | $0.02 | $0.05 | $0.13 | $0.08 | $0.09 |
| Shares | |||||
| Basic Shares Outstanding | 97.3M | 36.9M | 20.3M | 35.9M | 35.9M |
| Diluted Shares Outstanding | 97.3M | 36.9M | 20.3M | 35.9M | 35.9M |
| Profitability Metrics | |||||
| EBITDA | (100.6M) | (92.5M) | (74.4M) | (45.5M) | (29.1M) |
| D&A | 1.7M | 1.7M | 1.5M | 1.2M | 774.1K |
| EBIT | (102.4M) | (94.2M) | (75.9M) | (46.7M) | (29.9M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026